# Loop Industries, Inc.: overview LOOP · Nasdaq · CIK 1504678 · [Materials](/sectors/materials.md) · fiscal year ends Feb 28 Pages: [Overview](/companies/loop.md) · [Financials](/companies/loop/financials.md) · [Filings](/companies/loop/filings.md) · [Insiders](/companies/loop/insiders.md) Latest reported revenue: [$117.0k](/filings/0001437749-26-032746.md) for Q2 FY2027, three months to 2026-08-31, from the 10-Q filed Oct 16, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax, accession 0001437749-26-032746). ## Last eight quarters | Line item | Unit | Q3 FY2025 (2024-11-30) | Q4 FY2025 (2025-02-28) | Q1 FY2026 (2025-05-31) | Q2 FY2026 (2025-08-31) | Q3 FY2026 (2025-11-30) | Q4 FY2026 (2026-02-28) | Q1 FY2027 (2026-05-31) | Q2 FY2027 (2026-08-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.1](/filings/0001654954-25-000379.md) | [10.8 d](/filings/0001437749-26-018576.md) | [0.3](/filings/0001654954-25-008086.md) | [0.0](/filings/0001437749-25-031037.md) | [0.1](/filings/0001437749-26-001273.md) | [0.2 d](/filings/0001437749-26-018576.md) | [0.2](/filings/0001437749-26-023542.md) | [0.1](/filings/0001437749-26-032746.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | [(22907.7%)](/filings/0001437749-26-001273.md) | [63.7% d](/filings/0001437749-26-018576.md) | [(1367.5%)](/filings/0001437749-26-023542.md) | not reported | [(3423.3%)](/filings/0001437749-26-001273.md) | [(1536.4%) d](/filings/0001437749-26-018576.md) | [(1891.1%)](/filings/0001437749-26-023542.md) | [(2553.8%)](/filings/0001437749-26-032746.md) | | Diluted EPS | $ per share | [(0.25)](/filings/0001654954-25-000379.md) | not reported | [(0.07)](/filings/0001654954-25-008086.md) | not reported | not reported | not reported | not reported | not reported | | Free cash flow | $m | not reported | [6.5 d](/filings/0001437749-26-018576.md) | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2022 (2022-02-28) | FY2023 (2023-02-28) | FY2024 (2024-02-29) | FY2025 (2025-02-28) | FY2026 (2026-02-28) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | [0.0](/filings/0001654954-23-006894.md) | [0.2](/filings/0001654954-24-007029.md) | [0.2](/filings/0001654954-25-006337.md) | [10.9](/filings/0001437749-26-018576.md) | [0.5](/filings/0001437749-26-018576.md) | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | [(12312.7%)](/filings/0001654954-24-007029.md) | [(13782.4%)](/filings/0001654954-25-006337.md) | [(138.3%)](/filings/0001437749-26-018576.md) | [(2392.8%)](/filings/0001437749-26-018576.md) | | Diluted EPS | $ per share | not reported | not reported | [(0.44)](/filings/0001654954-25-006337.md) | [(0.32)](/filings/0001654954-25-006337.md) | not reported | | Free cash flow | $m | [(45.4)](/filings/0001654954-23-006894.md) | [(35.0)](/filings/0001654954-24-007029.md) | [(23.2)](/filings/0001654954-25-006337.md) | [(2.1)](/filings/0001437749-26-018576.md) | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Operating margin (operating income / revenue). XBRL Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/loop/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Jackson Hole Capital Partners, LLC](/funds/1767049.md) | 2026-03-31 | $341.1k | 238,501 | | Not compared | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $266.9k | 277,916 | | Reduced −86 | | [Lido Advisors, LLC](/funds/1650150.md) | 2026-06-30 | $228.0k | 237,501 | | New +237,501 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $218.4k | 227,492 | | Reduced −918 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $208.7k | 217,349 | | Unchanged | | [Corient Private Wealth LP](/funds/1948780.md) | 2026-06-30 | $208.4k | 217,130 | | Reduced −34,615 | | [NWF Advisory Services Inc.](/funds/2045735.md) | 2026-06-30 | $160.9k | 167,616 | | Unchanged | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $160.5k | 167,141 | | Unchanged | | [RENAISSANCE TECHNOLOGIES LLC](/funds/1037389.md) | 2026-06-30 | $145.1k | 151,100 | | Added +2,439 | | [FIFTH THIRD BANCORP](/funds/35527.md) | 2026-06-30 | $144.1k | 150,118 | | Unchanged | ## Recent filings [All 494 filings](/companies/loop/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 10:03 ET | [10-Q](/filings/0001437749-26-032746.md) | Quarterly report, period 2026-08-31 | 0001437749-26-032746 | | 2026-10-15 | 20:46 ET | [8-K](/filings/0001437749-26-032729.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-032729 | | 2026-10-01 | 20:10 ET | [8-K](/filings/0001437749-26-031737.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-031737 | | 2026-09-17 | 20:13 ET | [8-K](/filings/0001437749-26-030685.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-030685 | | 2026-09-08 | 20:13 ET | [8-K](/filings/0001437749-26-029827.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-029827 | | 2026-08-28 | 20:30 ET | [8-K](/filings/0001437749-26-029189.md) | 5.07 Shareholder vote results | 0001437749-26-029189 | | 2026-08-26 | 15:44 ET | [SCHEDULE 13D/A](/filings/0001821808-26-000006.md) | Ownership report, active investor, amended | 0001821808-26-000006 | | 2026-08-19 | 20:31 ET | [8-K](/filings/0001437749-26-028542.md) | 1.01 Entry into a material agreement; 8.01 Other events | 0001437749-26-028542 | | 2026-07-29 | 20:32 ET | [8-K](/filings/0001437749-26-024892.md) | 3.01 Delisting notice | 0001437749-26-024892 | | 2026-07-14 | 20:31 ET | [10-Q](/filings/0001437749-26-023542.md) | Quarterly report, period 2026-05-31 | 0001437749-26-023542 | ## Latest annual report [Form 10-K for the fiscal year ended Feb 28, 2026](/filings/0001437749-26-018576.md), filed May 27, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1504678 - Tickers: LOOP - Exchange: Nasdaq - SIC code: 2800 Chemicals & Allied Products - State of incorporation: NV - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:41 ET. No prices; not investment advice.